Julie Solis is Vice President of Pharmaceutical Technology with more than 30 years of pharmaceutical industry experience. She is responsible for overseeing and supporting internal and external technical transfer projects, project management activities and process improvement projects. Prior to her current role, she was General Manager of PLD’s Nicotine Replacement Therapy (NRT) Gum Facility and held numerous leadership roles of varying degrees during the site’s tenure under Watson, Actavis, Allergan and Teva. Julie holds an MBA from Adelphi University and BS Dual Major in Chemistry and Business Economics from SUNY Oneonta.
